Are you Dr. Brown-Glaberman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 University of New Mexico
1201 Camino de Salud MSC 074025
Albuquerque, NM 87131Phone+1 505-925-0404Fax+1 505-925-0408
Summary
- Dr. Ursa (Brown Glaberman) Brown-Glaberman, MD is an oncologist in Albuquerque, New Mexico. She is currently licensed to practice medicine in New Mexico and Arizona. She is affiliated with University of New Mexico Hospitals.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2010 - 2013- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2006 - 2010
University of New Mexico School of MedicineClass of 2006
Certifications & Licensure
NM State Medical License 2013 - 2025
AZ State Medical License 2009 - 2015- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014
Clinical Trials
- Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
- LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) Start of enrollment: 2014 Aug 25
- Join now to see all
Publications & Presentations
PubMed
- A Remotely Delivered Light-Intensity Physical Activity Intervention for Older Cancer Survivors: Protocol for a Feasibility Randomized Controlled Trial.Cindy K Blair, Ursa Brown-Glaberman, Scott T Walters, Claire Pestak, Tawny Boyce
JMIR Research Protocols. 2024-12-13 - NCCN Policy Summit: Cancer Across Geography.Sean T McCarson, Alyssa Schatz, Victoria Hood, Ashley Orr, Aaron Bailey
Journal of the National Comprehensive Cancer Network. 2024-05-31 - Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia
Cancer. 2024-05-15
Press Mentions
2-D or 3-D?October 16th, 2019- “Lobos Love Pink” Game Honors Breast Cancer Fighters and SurvivorsOctober 13th, 2017
